News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GNI Sees Demand For Synthetic Bone Material Product In China



10/2/2006 11:47:46 AM

TOKYO--(BUSINESS WIRE)--GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-BangTM, a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province. Shanghai Genomics received a Product Registration Certificate from the Chinese State Food and Drug Administration (SFDA) to market Gu-BangTM earlier this year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES